[1]
C. Oliva Guerrero, L. Barahona Acevedo, J. Castro Arenas, and C. Olavarría Leiva, “Impact on the quality of life of the treatment of adductor spasmodic dysphonia with botulinum toxin A”, Rev. Investig. Innov. Cienc. Salud, vol. 3, no. 2, pp. 24–34, Dec. 2021.